Sang Hoon Ahn

Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score

Hwai‐I Yang, Man‐Fung Yuen, Henry Lik‐Yuen Chan et al. · The Lancet Oncology · 2011 · 660 citations · Full text

Medicine, Biostatistics, Oncology +14

96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection

Kosh Agarwal, Maurizia Rossana Brunetto, Wai Kay Seto et al. · Journal of Hepatology · 2018 · 423 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +10

Risk Assessment of Hepatitis B Virus–Related Hepatocellular Carcinoma Development Using Liver Stiffness Measurement (FibroScan) σ

Kyu Sik Jung, Seung Up Kim, Sang Hoon Ahn et al. · Hepatology · 2010 · 385 citations · Full text

Medicine, Internal Medicine, Oncology +17

Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008‐2011)

Yong‐ho Lee, Seung Up Kim, Kijun Song et al. · Hepatology · 2015 · 346 citations · Full text

Medicine, Nutrition, Nutritional Sciences +17

Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B

Patrick Marcellin, Sang Hoon Ahn, Xiaoli Ma et al. · Gastroenterology · 2015 · 338 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17